Prognostic factors for overall survival in patients with advanced NSCLC – data from the clinical registry on lung cancer (TLK).

von Verschuer, U., Tessen, H.W., Eggert, J., Neise, M., Frank, M., Jänicke, M., Spring, L., Marschner, N., 2014.

Oncol Res Treat 37 (suppl 5)(V701), 227. doi:10.1159/000368945

Studie: TLK; Indikation: Bronchialkarzinom; Jahr: 2014; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com